Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  ABIOMED, Inc.    ABMD

ABIOMED, INC. (ABMD)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Abiomed : invests in Israeli medical device maker Magenta

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/28/2017 | 01:06pm CET

JERUSALEM (Reuters) - Israeli medical device company Magenta Medical said on Thursday it has raised $15 million in funding led by Massachusetts-based Abiomed Inc (>> ABIOMED, Inc.), a maker of catheter-based heart pumps, and venture capital firm Pitango.

JERUSALEM (Reuters) - Israeli medical device company Magenta Medical said on Thursday it has raised $15 million in funding led by Massachusetts-based Abiomed Inc (>> ABIOMED, Inc.), a maker of catheter-based heart pumps, and venture capital firm Pitango.

Japanese venture capital group JAFCO and a group of cardiovascular experts also invested in the round.

The Israeli startup is developing an apparatus for treating acute heart failure which it says can alleviate congestion faster and more safely than diuretics alone. Heart failure afflicts approximately 6.5 million people in the United States alone.

Ehud Schwammenthal, Magenta's co-founder and chief medical officer, said the company's first product was in clinical trials in Europe. The funding, he said, will allow the firm to expand the clinical programme, with the goal of getting approval in Europe and a second study going in the United States.

(Reporting by Dan Pleck; Editing by Tova Cohen)

Stocks treated in this article : ABIOMED, Inc., Medtronic PLC
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ABIOMED, INC.
02/15ABIOMED : Receives Approval for Expanded FDA Indication for High Risk Percutaneo..
AQ
02/15ABIOMED INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
02/14Abiomed Receives Approval for Expanded FDA Indication for High Risk Percutane..
GL
02/14ABIOMED : Announces Peripartum and Postpartum Cardiomyopathy Approval and Womens..
AQ
02/13ABIOMED : Announces Peripartum and Postpartum Cardiomyopathy Approval and Women'..
PU
02/13Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval and Women..
GL
02/13Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with..
GL
02/06ABIOMED INC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
02/01ABIOMED : beats 3Q profit forecasts
AQ
02/01ABIOMED (NASDAQ : ABMD) reported earnings of $0.70 per share beating Walls Stree..
AQ
More news
News from SeekingAlpha
02/15YOUR DAILY PHARMA SCOOP : Achaogen Update, Catabasis' Positive Results, Bristol-.. 
02/14FDA OKs expanded use for Abiomed's Impella 2.5 and CP heart pumps; shares up .. 
02/13FDA OKs expanded use for Abiomed's Impella heart pumps 
02/02YOUR DAILY PHARMA SCOOP : Synergy Update, Vertex Results, Affimed Data 
02/01ABIOMED's (ABMD) CEO Michael Minogue on Q3 2018 Results - Earnings Call Trans.. 
Financials ($)
Sales 2018 583 M
EBIT 2018 153 M
Net income 2018 107 M
Debt 2018 0,28 M
Yield 2018 -
P/E ratio 2018 114,64
P/E ratio 2019 82,57
EV / Sales 2018 19,8x
EV / Sales 2019 14,8x
Capitalization 11 542 M
Chart ABIOMED, INC.
Duration : Period :
ABIOMED, Inc. Technical Analysis Chart | ABMD | US0036541003 | 4-Traders
Technical analysis trends ABIOMED, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Average target price 281 $
Spread / Average Target 7,7%
EPS Revisions
Managers
NameTitle
Michael R. Minogue Chairman, President & Chief Executive Officer
David M. Weber Chief Operating Officer
Ian McLeod Controller, Chief Financial & Accounting Officer
Thorsten Siess Chief Technology Officer
Seth Bilazarian Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ABIOMED, INC.36.32%11 542
THERMO FISHER SCIENTIFIC9.71%83 531
DANAHER3.53%66 848
INTUITIVE SURGICAL12.32%45 927
BOSTON SCIENTIFIC CORPORATION8.15%37 200
ROYAL PHILIPS-1.49%36 661